News from Antibody Solutions

Roche Acquires Adheron Therapeutics and Lead Asset, SDP051
Adheron Therapeutics has been acquired by Roche in a deal worth up to $580 million. The lead asset, SDP051, a humanized monoclonal antibody targeting Cadherin-11, has completed Phase 1 of clinical dev... ...more, comments
Abs to Difficult Membrane Proteins
"Antibody Development Strategies for Difficult Membrane Proteins" will be presented by Dr John Kenney at the Discovery On Target meeting in Boston, Sept. 24, 2015 at 12:50 PM, Westin Boston Waterfront... ...more, comments
AAPS-NBC 2015 Exhibit Hall Pass
We are exhibiting at the AAPS National Biotech Conference June 8th and 9th at the Marriott Marquis in San Francisco. See below for the registration link and Promo Code for a free one-day conference... ...more, comments
Antibody Solutions to Attend AAPS National Biotechnology Conference
Antibody Solutions will be attending the AAPS National Biotechnology Conference, June 8-10, 2015 at the San Francisco Marriott Marquis. ...more, comments
Dr. Kenney Speaker at Peptalk 2015
Dr. John Kenney was a speaker for the Membrane Proteins Track, Discovery and Development of Antibody Targets. Dr. Kenney's talk was entitled "Strategies to Obtain Antibodies to Difficult Membrane Tar... ...more, comments


News-Medical.Net Antibodies News Feed

Latest Antibodies News and Research

An emergency blood transfusion mandates matching of the blood types so that the donor and the recipient are compatible in their blood types. There is no other matching between the blood bag and the recipient – race, ethnicity, religion, gender etc.
Posted: October 18, 2017, 4:12 am
The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States.
Posted: October 17, 2017, 2:34 am
IGeneX Inc., a CLIA and New York-approved Reference Laboratory, specializing in testing for tick-borne diseases, is pleased to announce the launch of three new tests that are more inclusive and specific for aiding in diagnosis of Borreliosis (Lyme Disease and Tick-Borne Relapsing Fever, Borreliosis).
Posted: October 16, 2017, 6:37 pm
Kalorama Information says that infectious disease immunoassays beat the IVD market and the overall IVD market in terms of revenue growth. Immunoassays are tests that are based on the binding of antibodies to antigens to identify the presence of a substance.
Posted: October 16, 2017, 5:38 pm
Young leukemia patients who were vaccinated against influenza were just as likely as their unvaccinated peers to develop flu, suggesting that additional steps are necessary to protect high-risk individuals. These findings from the St. Jude Children's Research Hospital study appear October 16, 2017, in the Journal of Pediatrics.
Posted: October 16, 2017, 5:56 am
Scientists at The University of Notre Dame have shown that disordered proteins have a structure very close to what would be expected for a truly random structure using a novel X-ray scattering (SAXS) analysis methodology.
Posted: October 13, 2017, 12:17 pm
Monash University researchers have revealed the role played by an enzyme that is pivotal to the process of clearing infection in the body.
Posted: October 12, 2017, 4:27 pm
Atomo Diagnostics, a world leader in innovative point-of-care, rapid diagnostic devices, announced today that its Atomo HIV Self Test has been granted CE Marking by a European Union Notified Body.
Posted: October 12, 2017, 11:28 am
Liberia’s Ebola outbreak has yielded a successful trial of two vaccines against the deadly infection that could provide protection for up to a year and is also deemed to be safe.
Posted: October 12, 2017, 6:20 am
Zika virus is mutating so fast in Brazilian patients that different serotypes of the pathogen could appear in the near future, as is already the case with dengue virus. This would hinder the production of a vaccine and impair the effectiveness of the diagnostic tests already developed.
Posted: October 11, 2017, 12:20 am